Publications & Recognition

Health Care MarketTrends | September 2019, Issue 2 – Law Firm Foley & Lardner LLP examine private equity investment in specialty areas of the healthcare industry, specifically dermatology and orthopedics. The article includes insight from Provident Healthcare Partners.

Physician services acquisitions in the past 90 days — orthopedics, GI & more – The physician services sector witnessed strong consolidation and investment activity in the second quarter of 2019, according to Provident Healthcare Partners.

Private Equity Accelerating Consolidation In The CDMO Market – Bill Bolding and AJ Shekar share their insight on consolidation in the CDMO space.

Cannabis, Hemp Producers Targeted in May Health-Care Deals – The health-care industry is getting into the weed business.

Health-Care Deals Steady, Strong Through First Third of 2019– Consistency is the name of the game for health-care industry transactions in 2019 so far.

INSIGHT: Health Care M&A Transactions on Pace to Set Record in 2019– March madness is over for college basketball fans, but it’s just the beginning of a fast-paced year for health-care M&A activity.

Baby Steps: Ob Hospitalist Group is working to improve women’s health care, one hospital at a time – AJ Shekar provides some insight on PE investment in hospital outsourcing businesses.

The PE time bomb — Provident’s Abe M’Bodj on where investment in GI is headed in 2019 – Abe M’Bodj analyzes the current state of the GI market and offers insights into what the rest of the year could look like as well as how all PE firms can coexist.

WellCare Purchase Positions Centene for More MA Growth – Kevin Palamara and Jon Brown share some of their insight on the medicare advantage space with Radar on Medicare Advantage.

BioScrip, Option Care Will Join Forces Within Infusion Market – Micheal Patton and Bill Bolding share some of their insight on the specialty pharmacy space with Radar on Specialty Pharmacy.

Long-Term Care Deals Dominate Health Industry in February– The long-term care sector continued its domination of health-care deals in February, Bloomberg Law’s transactions advisory board says.

Ophthalmic World Leaders (OWL) – An Interview with Eric Major – Eric Major is featured as the OWL Champion for the month of March.

‘Add-on Acquisition’ Deals in 2018 Were Key to PE Growth in Ophthalmology Sector, Report Finds – Consolidation activity within the ophthalmology sector remained very active through the fourth quarter of 2018, a year in which there were at least 10 transactions publicly disclosed in every quarter

Private Equity Interest in Hospice Acquisition Expected to Rise in 2019 – As more private equity firms enter the post-acute health care arena, hospice organizations are increasingly pursuing mergers and acquisitions as a growth strategy, according to the recently released 4th quarter 2018 Home Health & Hospice Update from Provident Healthcare Partners.

The Health-Care M&A Meter: Hot 2018 to Be Followed by Hotter 2019– The outlook for health-care mergers and acquisitions in 2019 suggests even more transactions this year as compared to 2018, with activity in the hospital and health system sector expected to continue, as well as increasing volume of deals in the physician services, home health. and health-care IT sectors.

National Partners In Healthcare acquires Anesthesia Resources — 4 details– Phoenix-based Anesthesia Resources joined Richardson, Texas-based National Partners in Healthcare.

M&A Activity in Orthopedics, GI & More Increased in Q4 — 6 numbers to know– Physician specialties such as gastroenterology, orthopedics and urology saw an uptick in private equity consolidation activity in the fourth quarter of 2018, according to Provident Healthcare Partners.

Private Equity Investments in Orthopedics Expected to Surge in 2019 — Avoid these risks– Robert Aprill shares some insight as to why we should expect to see more private equity recapitalization transactions in orthopedics in 2019.

Weighing the Potential Benefits and Risks of a Transaction– Steve Grassa’s article was featured in ADAM’s December/January issue of Executive Decisions in Dermatology.

Consolidation, Innovation, Flexibility Will Shape Year for MAOs – Kevin Palamara share’s some insight with AIS Health in Radar on Medicare Advantage.

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”